Research
Energy at cell level: what research is studying on coenzyme Q10
Coenzyme Q10 is not a vitamin: the healthy body makes it itself, in sufficient amounts.1 Even so, it has been tested as a supplement in many randomised trials, for example in heart failure, high blood pressure, type 2 diabetes, fatigue and fertility treatment.2-6
There are 2 ways of looking at Q10. Biochemically, it is a small, fat-soluble molecule in the inner mitochondrial membrane. There it passes on electrons that the cell needs to form adenosine triphosphate (ATP).1,7 Clinically, it is a substance whose supplementation has been studied for the heart, blood pressure, metabolism and oxidative stress (strain on cells from reactive oxygen compounds).2,3,8
Not every theoretically plausible effect is automatically clinically relevant.
This article sorts out what these studies measured, how solid they are and where the data remain thin.
What is coenzyme Q10, and where does it work in the body?
Coenzyme Q10 occurs in all living cells. In its oxidised form it is called ubiquinone, in its reduced form ubiquinol. Tissues with a high energy demand contain particularly large amounts: the heart, the kidneys, the liver and the muscles.1
Q10 performs its best-known task in the mitochondria. There it works as an electron shuttle in the respiratory chain, the point at which the cell obtains ATP. At the same time, as an antioxidant, it can protect cell membranes in particular from damage by free radicals.1,7
Both fit together: where a lot of energy is turned over, many reactive oxygen compounds arise as well. Chemically, Q10 incidentally resembles vitamin K and vitamin E.1
Does the body make Q10 itself, and which foods contain it?
Yes. The body builds Q10 from the amino acids phenylalanine or tyrosine and from mevalonic acid. Q10 is therefore not considered an essential nutrient.1 According to the German Federal Institute for Risk Assessment (BfR), no Q10 deficiency requiring treatment is known so far. There are no signs of an undersupply in the population.1
With a usual diet, a person takes in an estimated 3-6 mg of Q10 a day, about half of it in the reduced form.1,9 The richest sources are meat, fish, nuts and some oils. Fruit, vegetables, cereals and dairy products contain only 0.01-0.3 mg per 100 g.1,9

Through mevalonic acid, Q10 formation depends on the same metabolic pathway that statins inhibit. Statins are therefore thought to block Q10 formation as well, as the British HTA review notes.2 What this means in practice follows further below.
Is there an authorised health claim for Q10?
No. In 2010 the European Food Safety Authority (EFSA) examined the claims submitted for Q10. They included energy-yielding metabolism, blood pressure, protection from oxidative damage and endurance. EFSA considered none of them scientifically substantiated.1,10
None of these statements may therefore appear on products containing Q10. How this assessment works is explained in the article on EU health claims.
A study result is not an authorised health claim.
What follows are results from studies. Most of them were obtained in people with a pre-existing condition, in addition to their treatment.
What summaries of studies on Q10 have measured
Meta-analyses of randomised trials, mostly in people with a pre-existing condition, in addition to treatment
What do studies show on Q10 in heart failure?
Q10 has been studied longest in heart failure. The heart is among the organs with the highest energy demand, so the question is an obvious one.
A systematic review from the British Health Technology Assessment (HTA) programme included 26 trials with 2,250 participants. For all-cause mortality, 7 trials with 1,371 people were available. The relative risk was 0.68, but the confidence interval ranged from 0.45 to 1.03. A benefit is therefore possible, but not established.2
Many of the trials had a high or unclear risk of bias. The authors consider stronger evidence necessary before Q10 is prescribed in the British health service.2
The largest single trial is Q-SYMBIO with 420 people with moderate to severe heart failure. They received 100 mg of Q10 3 times a day or a placebo for 2 years, in addition to standard therapy. After 16 weeks there was no difference. After 2 years, 15% of the Q10 group had had a major cardiovascular event, compared with 26% in the placebo group.11
Q-SYMBIO: fewer events with Q10, in a single trial
Share of participants with an event after 2 years, in %
Major cardiovascular event
Death from any cause
Cardiovascular death
An older meta-analysis found an ejection fraction 3.67 percentage points higher, meaning a slightly larger share of blood that the heart pumps out with each beat.12 Q10 does not replace guideline-based therapy. It was studied as an adjuvant measure, in addition to standard treatment.2,12
What do studies show on Q10 and blood pressure?
A meta-analysis of 26 trials with 1,831 people with cardiovascular or metabolic disease found systolic blood pressure 4.77 mmHg lower. The relationship with the amount was U-shaped, most marked at about 100-200 mg a day. The authors rated the certainty of the evidence as moderate using the GRADE system.13
A more recent meta-analysis of 45 randomised trials found 3.44 mmHg less in the systolic value. The diastolic value and heart rate did not change significantly.3
A comprehensive meta-analysis covering 27 micronutrients counted Q10 among the substances with moderate- to high-quality evidence for cardiovascular risk factors. For all-cause mortality it reported a relative risk of 0.68.14
What do studies show on Q10 and oxidative stress?
The most frequently recurring finding concerns markers of oxidative stress. A GRADE-assessed meta-analysis pooled 34 randomised trials with 2,012 participants. With Q10, total antioxidant capacity (TAC) was higher. Malondialdehyde (MDA), a marker of fat oxidation, was lower.8
For the protective enzyme superoxide dismutase, the increase was not established in this work. The effects were clearer in coronary heart disease and type 2 diabetes, and most favourable in subgroups taking 100-150 mg a day.8
An umbrella meta-analysis, which pools existing meta-analyses, confirmed the direction for TAC and MDA and also found more superoxide dismutase.15 Oxidative stress links many fields, from blood vessels to training. That is why alpha-lipoic acid is also studied at this point.
What do studies show on Q10 and fatigue?
Many people are interested in Q10 because of exhaustion. A meta-analysis of 13 randomised trials with 1,126 participants found lower scores on fatigue scales with Q10. The direction was the same in healthy and ill participants.5
The difference was significant only with Q10 alone, not with combination products. Higher amounts and longer intake went along with larger differences. Among 602 people taking Q10, 1 adverse event in the digestive tract occurred.5
Q10 is not a stimulant like caffeine or theobromine. The studies measured fatigue scores, not energy. There is no authorised claim on fatigue or energy-yielding metabolism for Q10.10
What do studies show on Q10 in diabetes and metabolic syndrome?
For type 2 diabetes, one meta-analysis pooled 13 trials with 765 patients. With Q10, the long-term blood sugar value HbA1c and fasting blood sugar were somewhat lower; fasting insulin showed no difference.4
A further meta-analysis of 12 trials with 650 people with diabetes found no change in all metabolic values, but lower total and LDL cholesterol.16 In metabolic syndrome, higher adiponectin levels as well as fewer inflammation markers and less MDA were described, in 318 participants.17
All these studies were carried out in people with an existing metabolic disease, mostly in addition to treatment. What follows for people without a diagnosis has not been studied.
How consistent are the findings on inflammation?
For inflammation markers the picture is mixed. A meta-analysis of 9 trials with 428 participants found less TNF-α, but no significant difference in CRP and IL-6.18
The 2023 umbrella analysis reached different results for TNF-α and IL-6 depending on the statistical method. The authors themselves describe their findings on inflammation as to be read with caution.15 Inflammation markers fluctuate strongly, and study populations vary widely.
What do studies show on Q10 and fertility?
In men with idiopathic infertility, meaning without an identifiable cause, one meta-analysis pooled 9 trials with 781 participants. With Q10, sperm concentration, semen volume and motility were higher, as was the rate of clinical pregnancies.19
A second meta-analysis of 8 trials with 877 men found a higher total sperm count and better motility. For concentration it showed no significant difference, and the trials differed markedly.20 Oxidative stress in semen is regarded as an important factor in male infertility, hence the research question.20
In women undergoing fertility treatment, Florou and colleagues analysed 5 randomised trials with 449 women. Clinical pregnancies were more frequent with Q10, while live births and miscarriages showed no significant difference.6
More pregnancies, but no established difference in births
Clinical pregnancy rate in women undergoing fertility treatment, in %
What do studies show on Q10 in sport?
In sport, the evidence is thin. One systematic review calls the data inconclusive overall.21
A second review analysed 16 studies in athletes taking 30-300 mg a day. It found lower markers of oxidative stress and of muscle strain (creatine kinase, CK). It also found higher values for anaerobic performance, meaning short, very intense efforts.22
Endurance performance was not established by this. The data describe markers of recovery rather than a reliable increase in performance.21,22
Q10 and statins: what is established?
Statins lower cholesterol by slowing the formation of mevalonic acid, and so presumably Q10 formation as well.2 This gave rise to the research question of whether Q10 reduces muscle complaints on statins.
The meta-analyses contradict each other. One analysis of 12 trials with 575 participants found less muscle pain, weakness and cramp, but no change in creatine kinase.23 An earlier analysis of 6 trials with 302 participants found no significant effect on either pain or creatine kinase.24 In the HTA review on heart failure there was no difference between people with and without a statin.2
Which amounts and which form were used in studies?
The studies in this article mostly used 100-300 mg a day, in sport also from 30 mg.8,11,13,22 For systolic blood pressure the most favourable range was 100-200 mg, for markers of oxidative stress 100-150 mg.8,13
Q10 is fat-soluble and is absorbed slowly and to a limited extent. The peak blood level is reached after about 6 hours, and the half-life is about 33 hours. Solubilised preparations reached higher blood levels in studies.7

According to the BfR, whether ubiquinone or ubiquinol is the better choice cannot currently be judged: there are gaps in knowledge for both forms.1 How far the differences between the compounds of a single substance can reach is shown by the comparison of magnesium forms.
Food, studies, safety data: the amounts side by side
Coenzyme Q10 in milligrams per day
How well is Q10 tolerated, and what applies with medicines?
In studies with up to 300 mg a day, digestive complaints occasionally occurred. Nausea, heartburn, stomach complaints or diarrhoea are named, and isolated skin rashes. Whether more than 300 mg a day causes complaints more often has not been researched.1 The HTA review found no sign of more adverse events in heart failure.2
One safety assessment gives 1,200 mg a day as the observed safe level. Its authors work for a Q10 manufacturer.25 There is no legal maximum amount in the EU. In Germany, a 2014 general ruling by the Federal Office of Consumer Protection and Food Safety (BVL) allows up to 100 mg a day in food supplements.1
According to the BfR, whether Q10 interacts with blood pressure-lowering medicines or with coumarin-type anticoagulants has not yet been sufficiently studied. The BfR advises people who take such medicines to seek medical advice before taking preparations with more than 100 mg a day. Data are lacking for pregnant and breastfeeding women, children and adolescents; the BfR advises excluding them or clarifying intake with a doctor beforehand.1
What does the evidence say overall?
Only few data are available for healthy people.1 Most findings come from people with heart, vascular or metabolic disease who received Q10 in addition to their treatment.2,8,13
Sleep, exercise and a varied diet remain the foundation. What a supplement can and cannot do is set out in the article on diet and supplements.
Key takeaways
- The body makes Q10 itself. Food adds an estimated 3-6 mg a day; the BfR considers additional intake unnecessary.1,9
- No authorised health claim: in 2010 EFSA considered none of the submitted Q10 claims substantiated, including energy-yielding metabolism.1,10
- Heart failure and blood pressure: meta-analyses and the Q-SYMBIO trial report benefits in addition to therapy, but the evidence is not considered sufficiently robust.2,3,11
- Oxidative stress is the most frequently recurring finding; results on inflammation, statin muscle complaints and sport are inconsistent.8,18,21,23,24
- Amounts and tolerability: the studies mostly used 100-300 mg a day. Tolerability above 300 mg has not been researched, and interactions with medicines have been insufficiently studied.1,8,13
Sources
- German Federal Institute for Risk Assessment (BfR). Coenzyme Q10: what is known about health risks - and what is not? (in German). Questions and answers of 10 November 2023, accessed 15 November 2026.
- Claxton L, Simmonds M, Beresford L, et al. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. Health Technology Assessment, 2022.
- Karimi M, Pirzad S, Hooshmand F, et al. Effects of coenzyme Q10 administration on blood pressure and heart rate in adults: A systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology Cardiovascular Risk and Prevention, 2025.
- Zhang SY, Yang KL, Zeng LT, et al. Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. International Journal of Endocrinology, 2018.
- Tsai IC, Hsu CW, Chang CH, et al. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology, 2022.
- Florou P, Anagnostis P, Theocharis P, et al. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. Journal of Assisted Reproduction and Genetics, 2020.
- Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research, 2006.
- Dai S, Tian Z, Zhao D, et al. Effects of Coenzyme Q10 Supplementation on Biomarkers of Oxidative Stress in Adults: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials. Antioxidants, 2022.
- Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Critical Reviews in Food Science and Nutrition, 2010.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to coenzyme Q10 and contribution to normal energy-yielding metabolism, maintenance of normal blood pressure, protection of DNA, proteins and lipids from oxidative damage, contribution to normal cognitive function, maintenance of normal blood cholesterol concentrations and increase in endurance capacity and/or endurance performance pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010.
- Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC: Heart Failure, 2014.
- Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. American Journal of Clinical Nutrition, 2013.
- Zhao D, Liang Y, Dai S, et al. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition, 2022.
- An P, Wan S, Luo Y, et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. Journal of the American College of Cardiology, 2022.
- Dabbaghi Varnousfaderani S, Musazadeh V, Ghalichi F, et al. Alleviating effects of coenzyme Q10 supplements on biomarkers of inflammation and oxidative stress: results from an umbrella meta-analysis. Frontiers in Pharmacology, 2023.
- Dludla PV, Nyambuya TM, Orlando P, et al. The impact of coenzyme Q10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta-analysis of randomized controlled trials. Endocrinology, Diabetes & Metabolism, 2020.
- Dludla PV, Orlando P, Silvestri S, et al. Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials. International Journal of Molecular Sciences, 2020.
- Zhai J, Bo Y, Lu Y, et al. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. PLOS ONE, 2017.
- Bakri S, Saleh R, Cayan S, et al. Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials. World Journal of Men's Health, 2026.
- Akhigbe TM, Fidelis FB, Adekunle AO, et al. Does coenzyme Q10 improve semen quality and circulating testosterone level? A systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 2024.
- Drobnic F, Lizarraga MA, Caballero-García A, Cordova A. Coenzyme Q10 Supplementation and Its Impact on Exercise and Sport Performance in Humans: A Recovery or a Performance-Enhancing Molecule?. Nutrients, 2022.
- Fernandes MSS, Fidelis DES, Aidar FJ, et al. Coenzyme Q10 Supplementation in Athletes: A Systematic Review. Nutrients, 2023.
- Qu H, Guo M, Chai H, et al. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 2018.
- Banach M, Serban C, Sahebkar A, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clinic Proceedings, 2015.
- Hidaka T, Fujii K, Funahashi I, et al. Safety assessment of coenzyme Q10 (CoQ10). BioFactors, 2008.
ATLAS All-in-One - 35 ingredients, 4 capsules, once a day.
